These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 16619581

  • 1. High expression of Jun activation domain-binding protein 1 (Jab1) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
    Harada K, Kawashima Y, Yoshida H, Sato M.
    Anticancer Res; 2006; 26(2B):1615-9. PubMed ID: 16619581
    [Abstract] [Full Text] [Related]

  • 2. High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
    Harada K, Supriatno, Kawaguchi S, Kawashima Y, Itashiki Y, Yoshida H, Sato M.
    Anticancer Res; 2005; 25(3c):2471-5. PubMed ID: 16080478
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Low p27Kip1 expression is associated with poor prognosis in oral squamous cell carcinoma.
    Harada K, Supriatno, Yoshida H, Sato M.
    Anticancer Res; 2002; 22(5):2985-9. PubMed ID: 12530030
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Significance of Jab1 expression in human esophageal squamous cell carcinoma.
    Wang F, Wang Y, Yu X, Yang D, Wang Z, Lu C, Yuan Z, Xiao M, Shen A.
    J Clin Gastroenterol; 2009 Jul; 43(6):520-6. PubMed ID: 19349901
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
    Miyoshi T, Kondo K, Toba H, Yoshida M, Fujino H, Kenzaki K, Sakiyama S, Takehisa M, Tangoku A.
    Anticancer Res; 2007 Jul; 27(4C):2641-8. PubMed ID: 17695427
    [Abstract] [Full Text] [Related]

  • 9. Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
    Kurita H, Koike T, Miyazawa H, Uehara S, Kobayashi H, Kurashina K.
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):915-21. PubMed ID: 16835480
    [Abstract] [Full Text] [Related]

  • 10. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K, Ferdous T, Itashiki Y, Takii M, Mano T, Mori Y, Ueyama Y.
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer.
    Fukumoto A, Ikeda N, Sho M, Tomoda K, Kanehiro H, Hisanaga M, Tsurui Y, Tsutsumi M, Kato JY, Nakajima Y.
    Oncol Rep; 2004 Feb; 11(2):277-84. PubMed ID: 14719054
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity.
    Kunkel M, Moergel M, Stockinger M, Jeong JH, Fritz G, Lehr HA, Whiteside TL.
    Oral Oncol; 2007 Sep; 43(8):796-803. PubMed ID: 17207657
    [Abstract] [Full Text] [Related]

  • 13. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
    Kouvaraki MA, Rassidakis GZ, Tian L, Kumar R, Kittas C, Claret FX.
    Cancer Res; 2003 Jun 01; 63(11):2977-81. PubMed ID: 12782606
    [Abstract] [Full Text] [Related]

  • 14. The importance of immunohistochemical expression of EGFr in squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy.
    Smid EJ, Stoter TR, Bloemena E, Lafleur MV, Leemans CR, van der Waal I, Slotman BJ, Langendijk JA.
    Int J Radiat Oncol Biol Phys; 2006 Aug 01; 65(5):1323-9. PubMed ID: 16750322
    [Abstract] [Full Text] [Related]

  • 15. Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma.
    Närkiö-Mäkelä M, Pukkila M, Lagerstedt E, Virtaniemi J, Pirinen R, Johansson R, Kosunen A, Lappalainen K, Hämäläinen K, Kosma VM.
    Arch Otolaryngol Head Neck Surg; 2009 Oct 01; 135(10):1035-40. PubMed ID: 19841345
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
    Sui L, Dong Y, Watanabe Y, Yamaguchi F, Sugimoto K, Tokuda M.
    Oncol Rep; 2006 Apr 01; 15(4):765-71. PubMed ID: 16525656
    [Abstract] [Full Text] [Related]

  • 17. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Tsai TC, Yu CH, Cheng SJ, Liu BY, Chen HM, Chiang CP.
    Oral Oncol; 2008 Aug 01; 44(8):759-66. PubMed ID: 18061525
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of SENP5 in oral squamous cell carcinoma and its association with differentiation.
    Ding X, Sun J, Wang L, Li G, Shen Y, Zhou X, Chen W.
    Oncol Rep; 2008 Nov 01; 20(5):1041-5. PubMed ID: 18949399
    [Abstract] [Full Text] [Related]

  • 19. S100A2 expression as a predictive marker for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral cavity.
    Suzuki F, Oridate N, Homma A, Nakamaru Y, Nagahashi T, Yagi K, Yamaguchi S, Furuta Y, Fukuda S.
    Oncol Rep; 2005 Dec 01; 14(6):1493-8. PubMed ID: 16273244
    [Abstract] [Full Text] [Related]

  • 20. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
    Berg JP, Zhou Q, Breuhahn K, Schirmacher P, Patil MA, Chen X, Schäfer N, Höller TT, Fischer HP, Büttner R, Gütgemann I.
    Hum Pathol; 2007 Nov 01; 38(11):1621-7. PubMed ID: 17651785
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.